Structural Biology in Cancer Research

The main aim of integrating structural biology data into cancer research is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modelling mainly aims at drug designing. Consequently, a number of Structural Biologists are conducting cancer research, to speed-up the process of understanding the mechanism of biomolecules in order to improve the newer cancer therapies.

  • Membrane proteins
  • Cancer Systems Biology
  • Tumorigenesis
  • Cancer Heterogeneity
  • Epidemiology

Related Conference of Structural Biology in Cancer Research

September 22-23, 2020

International Conference on Nucleic Acids

Dubai, UAE
September 28-29, 2020

2nd International Conference on Metabolomics, Genomics and Proteomics

Singapore City, Singapore
September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
September 29-30, 2020

World Congress on Biosensors and Bioelectronics

Osaka, Japan
October 21-22, 2020

18th International Conference on Metabolomics and Proteomics

Frankfurt, Germany
December 07-08, 2020

9th World Congress on Glycobiology & Glycochemistry

Dubai, UAE
December 10-11, 2020

2nd Pathology and Infectious Disease Conference

Dubai, UAE
March 18-19, 2021

12th Tissue Repair and Regeneration Congress

Abu Dhabi, UAE
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic

Structural Biology in Cancer Research Conference Speakers

Recommended Sessions

Related Journals

Are you interested in